Published Papers & Misc - MORI MASAAKI

Division display  261 - 280 of about 646 ／  All the affair displays >>

  1. 森, 雅亮 and 岩田, 力 and 佐地, 勉 and 水田, 耕一 and 森本, 哲. パリビズマブの新しい使用の手引き　免疫不全児およびダウン症候群の児への適正使用を考える 小児科診療. 2013; 76 (11): 1843-1850.

  2. 清水, 博之 and 齋藤, 美和子 and 厚見, 恵 and 久保田, 千鳥 and 森, 雅亮. A群β溶連菌に対するペニシリン系とセフェム系抗菌薬の除菌率及び再発率 日本小児科学会雑誌. 2013; 117 (10): 1569-1573.

  3. 中野, 直子 and 森, 雅亮 and 横田, 俊平. 【血管炎-基礎と臨床のクロストーク-】最新の研究トピックス　AP-VAS 2012から　血管炎の臨床研究　小児期難治性原発性血管炎の全国調査 日本臨床. 2013; 71 (増刊1 血管炎): 516-520.

  4. Takenoue Yukiko, Kaneko Tetsuji, Miyamae Takako, Mori Masaaki, Yokota Shumpei. 大気中のNO2曝露による小児の喘息発症への影響　メタアナリシスによる検討(Influence of outdoor NO2 exposure on asthma in childhood: Meta-analysis) Pediatrics International. 2012.12; 54 (6): 762-769. ( ichushi )

  5. Yokota Shumpei, Imagawa Tomoyuki, Murata Takuji, Tomiita Minako, Itoh Yasuhiko, Fujikawa Satoshi, Takei Syuji, Mori Masaaki. 日本における若年性特発性関節炎に対するアダリムマブ使用に関する手引き(Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan) Modern Rheumatology. 2012.08; 22 (4): 491-497. ( ichushi )

  6. Uchimura Toru, Mori Masaaki, Nariai Akiyoshi, Yokota Shumpei. 日本におけるインフルエンザ(H1N1)2009感染小児の重症呼吸不全の症例分析(Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan) Journal of Infection and Chemotherapy. 2012.02; 18 (1): 59-65. ( ichushi )

  7. Imagawa, T. and Yokota, S. and Mori, M. and Miyamae, T. and Takei, S. and Imanaka, H. and Nerome, Y. and Iwata, N. and Murata, T. and Miyoshi, M. and Nishimoto, N. and Kishimoto, T.. Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis Mod Rheumatol. 2012; 22 (1): 109-115.

  8. Mori, M. and Imagawa, T. and Hara, R. and Kikuchi, M. and Hara, T. and Nozawa, T. and Miyamae, T. and Yokota, S.. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series J Rheumatol. 2012; 39 (4): 864-867.

  9. Hokosaki, T. and Mori, M. and Nishizawa, T. and Nakamura, T. and Imagawa, T. and Iwamoto, M. and Yokota, S.. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease Pediatr Int. 2012; 54 (1): 99-103.

  10. Harada, T. and Ito, S. and Mori, M. and Yokota, S.. Anatomical condition mimicking superior mesenteric artery syndrome might cause duodenal involvement in Henoch-Schonlein purpura Pediatr Int. 2012; 54 (4): 579.

  11. Imagawa, T. and Takei, S. and Umebayashi, H. and Yamaguchi, K. and Itoh, Y. and Kawai, T. and Iwata, N. and Murata, T. and Okafuji, I. and Miyoshi, M. and Onoe, Y. and Kawano, Y. and Kinjo, N. and Mori, M. and Mozaffarian, N. and Kupper, H. and Santra, S. and Patel, G. and Kawai, S. and Yokota, S.. Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan Clin Rheumatol. 2012; 31 (12): 1713-1721.

  12. 伊藤, 進 and 吉川, 徳茂 and 板橋, 家頭夫 and 岩田, 敏 and 宇理須, 厚雄 and 越前, 宏俊 and 大浦, 敏博 and 大塚, 頌子 and 河田, 興 and 佐地, 勉 and 佐藤, 淳子 and 中川, 雅生 and 中村, 秀文 and 牧本, 敦 and 森, 雅亮 and 日本小児科学会薬事委員会. ピボキシル基含有抗菌薬投与による二次性カルニチン欠乏症への注意喚起 日本小児科学会雑誌. 2012; 116 (4): 804-806.

  13. 粟生, 耕太 and 田中, 晶 and 塩島, 裕樹 and 平林, 文誉 and 白井, 加奈子 and 磯崎, 淳 and 大澤, 由記子 and 菊池, 信行 and 森, 雅亮 and 横田, 俊平. 新生児・乳児期早期に発症したヒトパレコウイルス3型の4例 日本小児科学会雑誌. 2012; 116 (4): 715-718.

  14. Yokota, S. and Kikuchi, M. and Nozawa, T. and Kizawa, T. and Kanetaka, T. and Miyamae, T. and Mori, M. A. and Nishikomori, R. and Takata, H. and Heike, T. and Hara, T. and Imagawa, T.. [An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab] Nihon Rinsho Meneki Gakkai Kaishi. 2012; 35 (1): 23-29.

  15. Yokota, S. and Kikuchi, M. and Nozawa, T. and Kizawa, T. and Kanetaka, T. and Miyamae, T. and Mori, M. A. and Nishikomori, R. and Takata, H. and Heike, T. and Hara, T. and Imagawa, T.. [An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab] Nihon Rinsho Meneki Gakkai Kaishi. 2012; 35 (1): 23-29.

  16. Yokota, S. and Kikuchi, M. and Nozawa, T. and Kizawa, T. and Kanetaka, T. and Kadota, K. and Miyamae, T. and Mori, M.. [Febrile responses in patients with pediatric rheumatic diseases] Nihon Rinsho Meneki Gakkai Kaishi. 2012; 35 (6): 511-519.

  17. Yokota, S. and Imagawa, T. and Murata, T. and Tomiita, M. and Itoh, Y. and Fujikawa, S. and Takei, S. and Mori, M.. Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan Mod Rheumatol. 2012; 22 (4): 491-497.

  18. Tsuda, K. and Iwasaki, S. and Horiguchi, H. and Mori, M. and Nishimaki, S. and Seki, K. and Taguri, M. and Yokota, S. and Ishiwada, N.. Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants Pediatr Int. 2012; 54 (1): 64-67.

  19. Takenoue, Y. and Kaneko, T. and Miyamae, T. and Mori, M. and Yokota, S.. Influence of outdoor NO2 exposure on asthma in childhood: meta-analysis Pediatr Int. 2012; 54 (6): 762-769.

  20. Shinoki, T. and Hara, R. and Kaneko, U. and Miyamae, T. and Imagawa, T. and Mori, M. and Yokota, S.. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab Mod Rheumatol. 2012; 22 (6): 871-876.

< PREV - NEXT >

To the head of this page.▲